West Pharmaceutical Services, Inc.
Market Cap
$17.24B
P/E Ratio
35.31
EPS
$6.78
Dividend Yield
0.37%
52-Week Range
$187.43 — $322.34
Volume
839.50K
Avg Volume
961.21K
Beta
1.18
P/E (TTM)
35.31
Forward P/E
30.39
PEG Ratio
58.53
P/S (TTM)
5.52
P/B (TTM)
5.36
P/FCF
141.65
EV/EBITDA
85.86x
EV/Sales
—
ROE (TTM)
0.17%
ROA (TTM)
0.12%
ROIC
0.05%
Gross Margin
0.36%
Operating Margin
0.20%
Net Margin
0.17%
Debt/Equity
0.10
Current Ratio
3.02
EPS Growth (YoY)
+0.04%
Revenue Growth (YoY)
+0.08%
EPS Growth (3Y)
-0.04%
EPS Growth (5Y)
+0.13%
Sales Growth (3Y)
+0.02%
Sales Growth (5Y)
+0.08%
EPS Est (This Year)
$7.88
EPS Est (Next Year)
$8.74
Dividend Yield
—
Annual Dividend
$0.22
Payout Ratio
0.11%
Frequency
—
Ex-Dividend Date
2025-11-12
Cash/Share
$10.94
Strong Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $304.43(27.2% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
71.94M
Float
71.50M
Free Float %
99.38%
RSI (14)
45.93
SMA 20
$246.81
SMA 50
$263.34
SMA 200
$253.79
ATR (14)
9.33
Volatility (Week)
0.04%
Volatility (Month)
0.03%
Pattern
—
1 Day
-2.16%
1 Week
+5.46%
1 Month
-11.60%
3 Months
-10.14%
6 Months
+1.34%
1 Year
—
YTD
-11.88%
All-Time High
$325.20
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
NYSE
IPO Date
1980-03-17
Employees
10600
CEO
Eric Green
Index Membership
S&P 500
Website
https://www.westpharma.com
West Pharmaceutical Services, Inc. (WST) is a healthcare company in the medical - instruments & supplies industry listed on the NYSE. With a market capitalization of $17.24B, a P/E ratio of 35.31, and a dividend yield of 0.37%, WST is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare WST against other stocks using dozens of fundamental and technical filters.
West Pharmaceutical Services, Inc. (WST) has a trailing twelve-month (TTM) P/E ratio of 35.31. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, West Pharmaceutical Services, Inc. (WST) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
West Pharmaceutical Services, Inc. (WST) has a market capitalization of $17.24 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Strong Buy" rating on West Pharmaceutical Services, Inc. (WST) with an average score of 1.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $304.43 implies 27.2% upside from the current price.
West Pharmaceutical Services, Inc. (WST) has returned -11.88% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.